KaiBiLi COVID-19 Antigen – kofin salwa
Gabatarwa
KaiBiLiTMCOVID-19 Na'urar Gwajin Saurin Gwajin Antigen gwaji ce ta in vitro wacce ta dogara da ƙa'idar immunochromatography don gano ƙimar 2019 Novel Coronavirus nucleocapsid protein antigens a cikin miya.Gano ya dogara ne akan ƙwayoyin rigakafi waɗanda aka haɓaka musamman ganewa da amsa tare da nucleoprotein na 2019 Novel Coronavirus.An yi niyya don taimakawa cikin saurin gano cutar ta SARS-CoV-2.
COVID-19 cuta ce mai saurin kamuwa da numfashi.Mutane gabaɗaya suna da sauƙi.A halin yanzu, marasa lafiya da suka kamu da cutar sankara ta coronavirus sune babban tushen kamuwa da cuta;Mutanen da suka kamu da asymptomatic suma suna iya zama tushen kamuwa da cuta.Dangane da binciken cututtukan cututtuka na yanzu, lokacin shiryawa shine kwanaki 1 zuwa 14, galibi daga kwanaki 3 zuwa 7.Babban alamun da suka hada da bayyanar cututtuka sun hada da zazzabi, gajiya da bushewar tari, cunkoso na hanci, yawan hanci, ciwon makogwaro, myalgia da gudawa a wasu lokuta.
Fasaloli & Fa'idodi
KaiBiLiTMCOVID-19 Gwajin Saurin Saurin Antigen gwaji ne na immunochromatographic don gano ƙimar 2019 Novel Coronavirus antigens.An yi nufin wannan gwajin don saurin dubawa a cikin dakin gwaje-gwaje.ƙwararren ƙwararren ƙwararren ne ya gudanar da wannan gwajin, sanye da kayan kariya masu dacewa (PPE).Gwajin saurin Antigen na COVID-19 yana da haruffa biyu akan saman na'urar gwajin da ke nuna layin gwaji (T) da layin sarrafawa (C).Layin gwaji da layin sarrafawa a cikin taga sakamako ba a bayyane kafin amfani da kowane samfuri.Layin kulawa shine layin tunani wanda ke nuna gwajin yana aiki yadda ya kamata.Dole ne layin sarrafawa ya bayyana duk lokacin da aka yi gwajin.Idan SARS-CoV-2 yana cikin samfurin, layin gwajin zai bayyana.Ana amfani da ƙwayoyin rigakafi masu zaɓaɓɓu ga SARS-CoV-2 azaman kamawa da ganowa a cikin binciken.Waɗannan ƙwayoyin rigakafi na iya gano antigens SARS-CoV-2 kai tsaye, tare da babban daidaito.
Ganewa
Gano ingancin 2019 Novel Coronavirus nucleocapsid protein antigens a cikin miya.
Misali
Saliba
Iyakar Ganewa (LoD)
SARS-CoV-2: 140 TCID50/ml
Daidaito
Yarjejeniyar Kashi Mai Kyau: 96.5%
Yarjejeniyar Kashi mara kyau: 97.8%
Yarjejeniyar Kashi Gabaɗaya:97.2%
Lokacin Sakamako
Karanta sakamako a cikin mintuna 15 kuma bai wuce mintuna 30 ba.
Yanayin Ajiye Kit
2 ~ 30 ° C.
Abubuwan da ke ciki
| Bayani | Qty |
| COVID-19 antigen gwajin na'urorin | 20 |
| Masu tara gishiri (kofin da lebe) | 20 |
| Plastic pipettes | 20 |
| Cire bututu (tare da buffer cirewar 0.5ml) | 20 |
| Nozzles tare da tace | 20 |
| Tube Tsaya | 1 |
| Saka Kunshin | 1 |
Bayanin oda
| Samfura | Cat. No. | Abubuwan da ke ciki |
| KaiBiLiTMCOVID-19 Antigen | P211140-C | Gwaje-gwaje 20 |
